Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Cheng Fang

Tracked across 1 events · 6 articles · First seen Aug 14, 2026 · Last active Aug 14, 2026

Sentiment
40
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 40
Business
Annovis Bio, Inc. (NYSE: ANVS) announced on August 14, 2026, that its pivotal Phase 3 Alzheimer's disease (AD) trial has reached full enrollment with 850 patients, exceeding the original target of 760. The trial evaluates…
Impact: Cheng Fang was promoted to Chief Scientific Officer, a move that strengthens the company's scientific leadership as it approaches key regulatory milestones. This promotion signals continuity and expertise in clinical execution.
Aug 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Cheng Fang live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.